ReviewCureus2024
Cancer: A Disease of Modern Times?
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Quercetin derivatives from Camellia sinensis for the discovery of anticancer compound against P-glycoprotein-mediated multidrug resistance: a computational approach.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Copper/Copper Oxide Nanoparticles: Biological Synthesis, Characterization and Potential Biomedical Applications: Advances and Perspectives.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Food-Derived Natural Compounds as Molecular Targets in Cancer Prevention.Pharmaceutics · 2026Review
- Applying biotechnology to overcome cancer drug resistance and improve public health outcomes.Osong public health and research perspectives · 2026Article
- Timing of hospice care initiation and aggressive care utilization in patients with cancer: a retrospective nationwide study in Korea.Frontiers in public health · 2026Article
- Breast Cancer Treatments: Drugs Targeting the PI3K/AKT/mTOR Pathway, TNBC Therapy and Future Directions: A Review.Life (Basel, Switzerland) · 2025Review
- Phytochemical Profile, Antioxidant Capacity and Anticancer Potential of Water Extracts from In Vitro CultivatedMolecules (Basel, Switzerland) · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a leading cause of mortality worldwide. Despite its prevalence, its origins remain a topic of debate, sparking discussion within the medical and historical professions. It had been feared for centuries, initially perceived as an incurable condition fraught with social stigma. This review details the historical records of cancer, tracing its earliest documented cases in ancient Egyptian and Greek civilizations, and follows the evolution of oncology treatment. Advances in medical technology and screening methods may have led to improved detection of cancer, with conditions that may have gone unnoticed in the past now diagnosed more frequently. Hippocrates and Galen later advanced the understanding of cancer by shifting from supernatural theories to a more scientific approach. The role of modifiable risk factors is highlighted, as well as the controversy surrounding the concept that cancer is a product of modern times. Environmental influences such as air pollution and tobacco smoke have been identified as carcinogenic, with public health campaigns subsequently developed. Whilst these preventative efforts aim to reduce such risks, evidence suggests that the causes of cancer are likely multi-faceted and, therefore, focusing solely on industrial factors may simplify a complex issue. The discussion remains open as to whether cancer is truly the product of modern industrialisation, or whether its low incidence in the past was due to less effective documentation and understanding. The apparent low prevalence of cancer in ancient times raises questions about the role of carcinogenic environmental factors in modern societies, with a need for continued research to explore its true origins and, therefore, develop effective strategies for prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.